Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James Lind
- PMID: 32838211
- PMCID: PMC7273049
- DOI: 10.1002/acg2.88
Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James Lind
Conflict of interest statement
None.
Similar articles
-
James F. Lind Sr. MD, CM, FACS, FRCC: a tribute to a surgical gastroenterologist and educator.Surg Endosc. 2011 Dec;25(12):3719-23. doi: 10.1007/s00464-011-1981-x. Epub 2011 Nov 4. Surg Endosc. 2011. PMID: 22052423
-
James Lind (1716-1794) & Captain Cook (1728-1779). Postal stamps issued on James Lind, stamp--Transkei 1993 and Captain Cook, stamps--Canada 1978.J Assoc Physicians India. 2007 Feb;55:158. J Assoc Physicians India. 2007. PMID: 17571753 No abstract available.
-
Patients/carers and clinicians can set joint priorities for research in cleft lip and palate.Int J Pediatr Otorhinolaryngol. 2013 Mar;77(3):309-10. doi: 10.1016/j.ijporl.2012.11.035. Epub 2012 Dec 17. Int J Pediatr Otorhinolaryngol. 2013. PMID: 23254243
-
SARS-CoV-2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective.Cell Biol Int. 2022 Jul;46(7):1009-1020. doi: 10.1002/cbin.11800. Epub 2022 Apr 2. Cell Biol Int. 2022. PMID: 35322909 Free PMC article. Review.
-
Progress in understanding COVID-19: insights from the omics approach.Crit Rev Clin Lab Sci. 2021 Jun;58(4):242-252. doi: 10.1080/10408363.2020.1851167. Epub 2020 Dec 29. Crit Rev Clin Lab Sci. 2021. PMID: 33375876 Review.
References
-
- Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70:86‐104. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous